(Q74152426)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Beta-blocker therapy in advanced heart failure: clinical characteristics and long-term outcomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

10

Swedberg K

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

7

Califf RM

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

O'Connor CM

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Gattis WA

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Zannad F

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

McNulty SE

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Gheorghiade M

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Adams KF

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

McKenna WJ

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Soler-Soler J

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Heart Failure

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

81-88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900004-X

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900004-X

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900004-X

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900004-X

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900004-X

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900004-X

Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900004-X

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900004-X

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900004-X

Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900004-X

10.1016/S1388-9842(98)00004-X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937984%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference